Ergocalciferol Versus Cholecalciferol in Non-Dialysis Dependent Chronic Kidney Disease Patients: A Small Retrospective Cohort Study
Purpose: The purpose of this retrospective cohort study was to measure the difference between cholecalciferol and ergocalciferol in their ability to effect vitamin D, parathyroid hormone (PTH), calcium, and phosphorous serum concentrations in patients with stage 3 or 4 chronic kidney disease. Method...
Saved in:
Main Authors: | Akram Al-Makki (Author), Kaitlin Frost (Author), Sang-A Yun (Author), Brian Overholser (Author), Brian Shepler (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2019-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lack of efficacy of ergocalciferol repletion
by: Thomas Wasser, et al.
Published: (2012) -
Tenapanor: A new treatment option for hyperphosphatemia in end stage kidney disease
by: Tiffany Lin, et al.
Published: (2022) -
Can Pentoxifylline be used as Adjunct Therapy to ACE Inhibitors and ARBs in Preserving Kidney Function?
by: Cody Carson, et al.
Published: (2016) -
Therapeutic update on oral potassium exchange resin use in chronic kidney disease patients: a systematic review of randomized controlled clinical trials
by: Jaclyn Gruver, et al.
Published: (2023) -
Oral versus intramuscular cholecalciferol replacement in hemodialysis patients with vitamin D deficiency
by: Maha A. Behairy, et al.
Published: (2022)